Home
Companies
SK Biopharmaceuticals

SK Biopharmaceuticals

Company

Also known as: SK Biopharmaceuticals

Company Profile

SK Biopharmaceuticals is a South Korean pharmaceutical company focused on CNS disorders and oncology, with global drug development and commercialization activities.

Website: https://www.skbp.com
Headquarters: Seongnam-si, South Korea
Founded: 2011
Stock Ticker: KRX:326030

Related News

Korean Biotechs to Present Next-Gen Cancer Therapies at AACR Meeting

Apr 08, 2026

Korean biotech firms will present next-generation cancer therapies at the AACR meeting, including CAR-T platforms for solid tumors, mRNA-based treatments, radiopharmaceuticals, and bispecific antibody ADCs. Companies like AbClon, Verismo Therapeutics, Hanmi Pharmaceutical, and SK Biopharmaceuticals will showcase their latest research.

Pharmaceutical Industry Shifts to Fewer, Larger AI-Driven Drug Development Partnerships

Mar 19, 2026

Global pharmaceutical R&D deal values surged 49% to $86.7 billion in 2025 as companies concentrate investments in AI-powered drug discovery platforms, with average deal sizes reaching a record $1.16 billion despite fewer total partnerships.